6CM
TELA icon

683 Capital Management’s TELA Bio TELA Stock Holding History

683 Capital Management’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-16,990
Closed -$181K – 244
2023
Q1 		$181K Hold
16,990
– – 0.01% 170
2022
Q4 		$195K Buy
+16,990
New +$152K 0.02% 168

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

683 Capital Management's TELA Position: Q2 2023 in Review

683 Capital Management sold out of TELA Bio (TELA) in Q2 2023, closing a stake of 16,990 shares — an estimated $181K sold.

683 Capital Management first reported a position in TELA in Q4 2022 and held it in 2 quarters. The position peaked at $195K in Q4 2022. 67 funds tracked by Wall St. Rank hold TELA as of Q2 2023.

  • 683 Capital Management reported no remaining TELA Bio position as of Q2 2023 after selling out during the quarter.
  • 683 Capital Management sold 16,990 TELA Bio shares in Q2 2023, an estimated $181K.
  • 683 Capital Management first reported a position in TELA Bio in Q4 2022 and held it in 2 quarters.
  • 683 Capital Management's TELA Bio position peaked at $195K in Q4 2022.
  • 67 funds tracked by Wall St. Rank held TELA Bio as of Q2 2023.

Based on 683 Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.